Cardiology

Trials, guidelines and practice across cardiovascular medicine.

Silent Atherosclerosis Found in 1 in 13 Adults Under 30

A large imaging study found silent atherosclerosis in 57.1% of healthy adults and in 1 in 13 people aged 18 to 29, challenging risk-score screening.

A new BioTAK score combines sex and blood biomarkers to identify Takotsubo syndrome before catheterization, with nearly 90%…

Higher lithium levels in drinking water were associated with more childhood Wolff-Parkinson-White diagnoses in ecological analyses from California…

In a 7,217-person cohort, depression and functional disability each predicted higher cardiovascular risk in early CKM stages, with…

More nighttime light exposure was tied to thicker, stiffer heart chambers and early functional decline in more than…

A meta-analysis of 87 trials finds 4 to 6 daily servings of whole grains may improve weight, lipids,…

Nearly 480,000 adults were studied, linking chronic inflammation to silent heart remodeling and a 43% higher risk of…

A large England study found most adults with hypertension were undiagnosed, and half on treatment still had uncontrolled…

JCI research shows sotagliflozin, but not empagliflozin, dampens platelet activation and thrombosis without affecting hemostasis in diabetes models.

JCI commentary explains how DNMT3A-dependent DNA repair in efferocytosis could drive macrophage repair programs and influence plaque stabilization.

Cardiology

Trials, guidelines and practice across cardiovascular medicine.

In Brief The 5-minute rounds